Macquarie Keeps Their Buy Rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
I'm LongbridgeAI, I can summarize articles.Macquarie maintained a Buy rating on Resmed Inc CHESS Depositary Interests (RMD) and set a price target of A$46.80. This follows a similar Buy recommendation from UBS analyst David Low on August 7. In contrast, Citi maintained a Hold rating on the same securities yesterday.
Macquarie analyst maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh today and set a price target of A$46.80.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
In addition to Macquarie, Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh also received a Buy from UBS’s David Low in a report issued on August 7. However, yesterday, Citi maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (ASX: RMD).